Autopsy report · NCT02773797
Placebo Controlled Evaluation of Sedation and Physiological Response to Intranasal Dexmedetomidine in Severe COPD
Cause of deathNo reason given
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- Dayton VA Medical Center
- Sponsor type
- US federal agency
- Conditions
- COPD
- Interventions
- IN-DEX 1.0 mcg/kg, intranasal saline; IN-DEX 1.5 mcg/kg, intranasal saline; Placebo - Saline
- Participants
- 0
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.